Haemonetics Shares Rally on CSL Supply Agreement Update

Key Facts

Haemonetics Corporation shares gained value following an update regarding its supply agreement with CSL. Seeking Alpha reported that the market reacted positively to the latest developments in the supply relationship between the two healthcare entities, which involves the deployment of devices throughout CSL's U.S. plasma collection centers.

HAE closed at $101.71 on October 7, 2026, with the stock trading between a day low of $101.32 and a high of $104.02 during that session. The positive price action reflects investor sentiment surrounding the clarification of terms within the company's core business contracts.